eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

6/2019
vol. 11
 
Share:
Share:
more
 
 
Original paper

HAPPY – Humanity Assurance Protocol in interventional radiotheraPY (brachytherapy) – an AIRO Interventional Radiotherapy Study Group project

Valentina Lancellotta
1
,
Vitaliana De Sanctis
2
,
Patrizia Cornacchione
1
,
Fernando Barbera
3
,
Vincenzo Fusco
4
,
Cristiana Vidali
5
,
Sara Scalise
1
,
Giulia Panza
6
,
Angela Tenore
1
,
Giuseppe Ferdinando Colloca
1
,
Renzo Corvò
7
,
Maria Antonietta Gambacorta
1, 6
,
Stefano Maria Magrini
8
,
Luca Tagliaferri
1

1.
UOC Radioterapia Oncologica, Dipartimento di Diagnostica per immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
2.
Department of Radiation Oncology, Faculty of Medicina e Psicologia, Sant’Andrea Hospital, University of Rome “La Sapienza”, Rome, Italy
3.
Brachytherapy Section, Radiation Oncology Department, Ospedali Civili Hospital and Brescia University, Brescia, Italy
4.
Department of Radiation Oncology, Centro di Riferimento Oncologico Regionale, Rionero in Vulture, Potenza, Italy
5.
Department of Radiation Oncology, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), Trieste, Italy
6.
Università Cattolica del Sacro Cuore, Rome, Italy
7.
Radiation Oncology, IRCCS Ospedale Policlinico San Martino and Department of Health Science, University of Genoa, Italy
8.
Radiation Oncology Department, Ospedali Civili Hospital and Brescia University, Brescia, Italy
J Contemp Brachytherapy 2019; 11, 6: 510–515
Online publish date: 2019/12/25
Article file
- HAPPY.pdf  [0.28 MB]
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
 

Purpose

Interventional procedures may produce emotional distress (e.g. anxiety and depression) particularly in interventional radiotherapy (IRT, brachytherapy – BT) because patients are not always asleep and sedated and therefore live the entire procedure with stress. The anxiety and depression may reduce compliance with treatment, could prolong hospitalization and compound the physical consequences of the disease. The patient’s psychological status during the procedures can influence the clinical outcome [1,2,3].

Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) are currently extremely relevant in cancer management and therapeutic choice. In the scenario of personalized medicine [4,5,6,7,8], a multidisciplinary approach is necessary to ensure that patients will be fully informed about treatment but also to obtain their inner serendipity. Instead of that, several studies have been focused on informational needs, time spent to do that, and treatment options [9,10,11,12,13] but there is just sparse research on patients’ expectations on treatment, quality of life during and after procedures, reported outcomes and experiences [14].

Thus, it is fundamental to explore the patients’ values and perspectives, as these are associated with treatment satisfaction, improved disease perception, anxiety, depression, improved quality and quantity of life [15,16,17,18]. Moreover, a link has been observed between patient satisfaction with the quality of service provided and at the same time survival outcomes related to several oncological settings [19,20,21,22].

Women affected by cancer fear a recurrence, feel sexual dysfunction, identity disturbance and high psychological distress [23]. There are several sources of evidence about how gynecological cancer patients experience physical and psychological symptoms, such as uncertainty, anxiety and depression [24].

Recently, the literature has focused on gynecologic cancer survivors and the information needs of this population [25,26,27]. Stewart et al. showed that psychological variables and disease severity are related to an increased desire of information and shared decision-making, and a component of decision-making was patient treatment preference [27]. Many patients seem to have difficulties in formulating their questions and being crucially involved in the treatment decision-making process [28,29]. If patients do not feel adequately involved, lower satisfaction, increased decisional regret and anxiety can be the consequences [30]. Despite the high need for research in the field of doctor–patient communication, there are only a few studies addressing these aspects in gynecological cancer patients [31].

The aim of our study was to examine the needs of patients and their values, expectations and preferences among patients affected by gynecological cancer, focused especially on physician–patient communication and treatment approach, as well as on the need for information concerning therapy effectiveness, side effects, toxicities, by the analysis of collected data as means of generating working hypotheses. This paper would like to propose a series of interventions/recommendations (HAPPY – Humanity Assurance Protocol in interventional radiotheraPY) to guarantee a sensitive approach in order to favor the psychological well-being of the patient during interventional radiotherapy. The project was conceived and implemented within the framework of the study group of BT, interventional radiotherapy and intra-operative radiotherapy (IORT), of the Associazione Italiana di Radioterapia ed Oncologia Clinica (AIRO – Italian Association of Radiotherapy and Clinical Oncology).

Material and methods

A specific Multiprofessional Task Group (MTG) was defined in order to analyze the needs of the patients. The MTG is composed of 1 interventional radiation oncologist (VL), 1 geriatric oncologist (GFC), 1 nurse (SS), 1 psychologist (AT), 1 resident in radiation oncology (GP) and 1 RT technician (PC). The multiprofessional structure was chosen to assess the needs of different perspectives (multi-dimensional approach). Indeed in our institution, the patient meets during the treatment, routinely, these professionals.

A total of 30 patients affected by gynecological cancer (25 endometrial and 5 cervix) and treated with endovaginal high-dose-rate IRT (HDR-IRT) at Interventional Oncology Center (IOC) of Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy were selected from January 2019 to March 2019.

All patients were treated following the institutional internal protocol that provides, before the implant, external genital depilation, perineum sterilization and bladder catheter positioning in order to have a similar bladder filling during the sessions following the first and for better contouring of the bladder. Based on the gynecological examination, the size of the vaginal applicator is chosen (median diameter 3 cm; range 2.5-3.5) and then it is fixed with a specific vaginal block. Usually we use local transmucosal anesthesia for reducing the applicator pain. Then a rectal probe is inserted, and 3D-CT is performed for treatment planning. After the procedure the bladder catheter is removed. The institutional interventional radiotherapy protocol in adjuvant settings is different from the exclusive IRT as well as from the boost after external beam radiotherapy (EBRT) protocol. The boost after 45 Gy EBRT is delivered with 5 Gy in 2 fractions prescribed to 0.5 cm from the surface of the applicator, while the exclusive IRT is delivered in 6 Gy × 4 fractions prescribed to 0.5 cm from the surface of the applicator.

Each member of the MTG spoke with the patients to examine their needs and to investigate their fears and perceptions. We performed several independent multi-dimensional conversations with the patients. Every conversation started with a simple question: “What makes this therapy uncomfortable for you?”. This process was repeated with each member of the multi-professional team and for each patient. Every patient has had 6 different conversations, which results in a total of 180 conversations. In this way, we applied a multi-dimensional approach to interpret the real needs of patients. After this step, the MTG planned two meetings: the first one to collect, after a long discussion, all the needs coming from patients and to identify common general needs (clusters); the second one, after 15 days, to finalize the classification selecting the needs more represented as result of the 180 multi-dimensional talks (definitive clusters).

The results of the task group were subjected to evaluation by an Expert Team (ET) of 4 physicians from 4 different institutions for a final evaluation (VDS – Rome, VF – Rionero in Vulture, FB – Brescia, CV – Trieste) for a final evaluation. Both teams discussed the patients’ needs to generate a list of necessary interventions/recommendation to fill every single need in order to obtain their inner well-being (Table 1).

Table 1

General cluster and HAPPY interventions/recommendations

Patient’s needs/issues general clustersHAPPY interventions/recommendations
1Lack of information and the fear of “unknown”Procedure information booklet, possibly with FAQs, and sharing patient story, to be delivered many days before the therapy Improving the patient’s participation in therapeutic choices also using decision support tools and discussing predictive models
2Comfortable and relaxing environmentPossibility of hearing music chosen by the patient and/or watching relaxing videos
3Ability to reduce anxietyPsychological support in the interventional room and/or prescription of anxiolytics if necessary
4Fear of the word “Bunker”Use alternative words like “Interventional Room” or “Treatment Room”
5Use of the word “Brachytherapy” often not known and heard for the first time by the patientUse a more conventional term such as “interventional radiotherapy”
6Embarrassment over external genital depilation (if necessary) in the interventional roomSuggestion to perform external genital depilation at home
7Discomfort due to the long maintenance of the bladder catheterThe bladder catheter will be placed in the interventional room just before the procedure
8Sense of loneliness in the roomIf possible, an operator holds the patient’s hand during the applicator positioning and plans optimization making human proximity perceived

[i] FAQ – frequently asked questions

The interventions list has been defined HAPPY (Humanity Assurance Protocol in interventional radiotheraPY). It consists of a protocol that could be adopted by the centers to guarantee humanity and better-quality care and compliance with therapeutic proposals.

Finally, a Master Team (MT) composed by the Chair of Brachytherapy, Interventional Radiotherapy and IORT study groups (LT), a member of AIRO Committee (MAG), the Chair of the Scientific Commission of AIRO (RC) and the AIRO president (SMM) performed an independent check of the project and endorsed it. The project phases are described in Table 2.

Table 2

Project workflow

PhaseTeam’s nameTeam membersTask
1Multiprofessional Task Group1 interventional radiation oncologist 1 geriatric oncologist 1 nurse 1 psychologist 1 resident in radiation oncology 1 RT technicianPatient interview Clusters needs definition
2Expert Team4 physicians from 4 different institutionsMultiprofessional Task Group results evaluation
3Multiprofessional Task Group + Expert TeamMultiprofessional Task Group members Expert Team membersDiscussion on the patient’s needs Generation of a list of necessary interventions (HAPPY)
4Master TeamBrachytherapy, Interventional Radiotherapy and IORT Study Group Chair AIRO Committee Member Chief of AIRO Scientific Commission AIRO PresidentProject independent check Endorsement

[i] IORT–intra-operative radiotherapy, HAPPY – Humanity Assurance Protocol in interventional radiotheraPY, AIRO – Italian Association of Radiotherapy and Clinical Oncology

Results

Thirty patients affected by endometrial cancer (83.3%) and cervix cancer (16.7%) were interviewed. The median age was 62.5 years (range 39-83 years). All patients had upfront surgery followed by adjuvant external beam radiotherapy plus HDR-IRT (66.6%) or HDR-IRT (33.4%) alone as exclusive treatment after surgery. Each member of the MTG has collected on average 3 needs/issues (range 2-8). The MTG defined 8 general clusters.

Based on the internal procedure the patient received 2 conversations regarding the procedure and for signing the informed consent: one during the first patient evaluation and another on the day before the procedure. Although 70% of the patients reported that they had received very good information about the procedure before the treatment (first moment) and all patients reported that the information had been completed in the second discussion (the day before the procedure) with the physicians, 100% of the patients suggested that having a small book of explanations can decrease the possible “lack of information and fear of the unknown” because not all the information can be understood the first time, so they can read it calmly at home”.

This issue could be managed using a procedure information booklet, possibly with FAQs (frequently asked questions), to be delivered before the therapy. Not knowing what to expect and the fear of feeling pain were a significant source of concern, sadness, and vulnerability for most of the patients (76.6%). They felt that sharing stories with other patients, at the same time, helped to provide reassurance as well as a sense of community or family. All patients did not appreciate the use of the word “bunker” used to describe the treatment place. In 33.3% of patients the word “brachytherapy” determined insecurity because it was often the first time they heard this term, while the term “interventional radiotherapy” reassured because it was more familiar and meant a minimally invasive procedure. Ninety percent of patients preferred to perform the external genital depilation at home and 80% of them would like the bladder catheter to be placed immediately before the procedure, avoiding a long stay with the catheter in place.

The anxiety, fear, worry, and vulnerability could be decreased through psychological support and creating a comfortable environment, and setting up a monitor in the room with which the patient could listen to music or watch videos.

The expert group accepts the classification without changes. MTG and ET defined nine HAPPY interventions/recommendations as reported in Table 1. The Master Team approved the protocol without changes.

Discussion

The present paper is focused on the lack of knowledge related to the needs and expectations of patients affected by gynecological cancer, with the aim to hypothesize solutions able to improve the patients’ emotional and sensitive status. Positive behavior may improve patient–physician communication and lead to shared clinical decision-making, better quality care and compliance with therapeutic proposals. Each staff member has an important role in the patient’s management: the physician and the residents are an essential source of information as well as symptom management; the psychologist provides psychological support; the nurses and medical radiology technicians are fundamental to reassure and accompany patients during treatment. All the staff together helps coping with the disease [32,33,34,35,36,37,38].

Shared decision-making is based on the interaction between physician and patient, while the patient’s treatment choices are influenced by different factors such as age, socioeconomic status, educational level, language, country-specific data such as geographic area, urban or rural context, spirituality, gender, sexual orientation, occupation, and disability defined culture [39,40]. Cultural factors shape patients’ perceptions of disease and their responses to treatments [41,42]. Several studies have found that the involvement of patients in the decision is a strong indicator of satisfaction, and the decision-making process can be improved if patients are aided in understanding treatment options [30,43].

The choice of the physician to decide which type of information has to been shared with the patients may be influenced by the physician’s perception of how the patient has understood information, the relationship with the patient, the physician’s perception of the patient’s vitality, the patient’s information comprehension and emotional well-being. On the basis of these data the physician can use explanations tailored or framed on the patient’s features and ability or understanding or analogies used to clarify the information given. The autonomy of cancer patients is always related to/limited by their social and cultural scenario, beliefs, and social status [30,43].

Physicians, moreover, share the information with the patients also on the basis of the patient’s age or socioeconomic status. Step et al. conducted an observational study on 40- to 80-year-old patients with breast cancer. The study results showed that physicians communicated with older patients in a more direct, slower manner than with younger patients, giving to older patients a single treatment recommendation while they gave more treatment options to younger patients [44]. The behavior of patients in the various age groups is also different. Younger patients appear to be more demanding, while older patients required less information [45,46,47,48,49]. Probably, to overcome the problem of “incomplete or not understandable” information, a complete informative booklet or brochure could help [50,51].

Even if today we tend, guaranteeing radiation protection, to perform treatments, based on technology and type, in protected areas with a less claustrophobic impact, another important point is the environment and the atmosphere in which the patients underwent the treatment. Music therapy may aid in anxiety management [52] and may be especially beneficial in cases of high baseline anxiety; it may produce significant anxiety reduction in only 5 minutes [52,53,54]. The preferred music may stimulate the relaxation response through activation of the parasympathetic system, because it delivers what is expected. Familiar melodies may help to relieve the stress, restoring balance to the autonomic nervous system [52,53,54].

Another concern of patients was the fear of feeling pain during the procedure [55,56]. Several studies have demonstrated the clinical potential offered by psychological interventions [57,58,59], especially in the context of pain, documenting a significant association between anxiety/depression scores and pain [60,61,62]. The phenomenon of placebo analgesia is entering routine clinical practice [63] because it was shown that placebo analgesia uses similar neurobiological mechanisms as those of pharmacological analgesic treatment [59,60,61,62]. Interventions that optimize treatment expectations and thus engage placebo mechanisms reportedly have a medium to large effect on experimental and acute procedural pain [64]. Furthermore, various aspects of doctor–patient communication, including the number and duration of medical briefings as well as warmth and empathy of communication, demonstrably increase the magnitude of placebo effects [61,65,66]. Another finding supported by the literature which was mentioned by participants during focus groups was the importance of having family or friends present at appointments [67].

The complexity of cancer care potentially enhances some of the inherent tensions in all patient–doctor communication. The use of the same words may produce misunderstanding between doctors and patients but also may create unfounded fears [40]. The patients need to understand not only the meaning of the word but also its potential limitations. The patient and the physician, therefore, must often negotiate between their different views of illness and of health to achieve their common therapeutic aim. Further studies should focus on these aspects using a well-planned structural method to provide evidence for a tailored clinical approach.

Conclusions

The aim of the present paper was to produce a protocol consisting in interventions/recommendations that could improve the internal serendipity and emotional state of patients undergoing HDR-IRT. The staff’s role is important not only as a source of information about the disease but also in coping with the disease.

Disclosure

The authors report no conflict of interest.

References

1 

Guo ZTang HYLi Het al.. The benefits of psychosocial interventions for cancer patients undergoing radiotherapy. Health Qual Life Outcomes 2013; 11: 121.

2 

Andersen BLYang HCFarrar WBet al.. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer 2008;113:3450-3458.

3 

Vetter DBarth JUyulmaz Set al.. Effects of art on surgical patients: a systematic review and meta-analysis. Ann Surg 2015; 262: 704-713.

4 

Tagliaferri LPagliara MMMasciocchi Cet al.. Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma. J Contemp Brachytherapy 2017; 9: 540-547.

5 

Kovács GTagliaferri LValentini V. Is an Interventional Oncology Center an advantage in the service of cancer patients or in the education? The Gemelli Hospital and INTERACTS experience. J Contemp Brachytherapy 2017; 9: 497-498.

6 

Tagliaferri LPagliara MMFionda Bet al.. Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): single institution experience and systematic literature review. J Contemp Brachytherapy 2019; 11: 54-60.

7 

Tagliaferri LKovács GAristei Cet al.. Current state of interventional radiotherapy (brachytherapy) education in Italy: results of the INTERACTS survey. J Contemp Brachytherapy 2019; 11: 48-53.

8 

Lancellotta VKovács GTagliaferri Let al.. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer. J Geriatr Oncol 2018; pii: S1879-4068(18)30259-5.

9 

Schulman-Green DBradley EHNicholson NRet al.. One step at a time: self-management and transitions among women with ovarian cancer. Oncol Nurs Forum 2012; 39: 354-360.

10 

Andersen MRSweet ELowe KAet al.. Involvement in decision-making about treatment and ovarian cancer survivor quality of life. Gynecol Oncol 2012; 124: 465-470.

11 

Luketina HFotopoulou CLuketina RRet al.. Treatment decision-making processes in the systemic treatment of ovarian cancer: review of the scientific evidence. Anticancer Res 2012; 32: 4085-4090.

12 

Stewart DEWong FCheung AMet al.. Information needs and decisional preferences among women with ovarian cancer. Gynecol Oncol 2000; 77: 357-361.

13 

Howell DFitch MIDeane KA. Impact of ovarian cancer perceived by women. Cancer Nurs 2003; 26: 1-9.

14 

Jenkins VCatt SBanerjee Set al.. Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the U.K.: results from the ADVOCATE study. Br J Cancer 2013; 108: 2264-2271.

15 

Husson OMols Fvan de Poll-Franse LV. The relation between information provision and health-related quality of life, anxiety, and depression among cancer survivors: a systematic review. Ann Oncol 2011; 22: 761-772.

16 

Mallinger JBGriggs JJShields CG. Patient-centered care and breast cancer survivors’ satisfaction with information. Patient Educ Couns 2005; 57: 342-349.

17 

Iskandarsyah Ade Klerk CSuardi DRet al.. Satisfaction with information and its association with illness perception and quality of life in Indonesian breast cancer patients. Support Care Cancer 2013; 21: 2999-3007.

18 

Husson OThong MSMols Fet al.. Illness perceptions in cancer survivors: what is the role of information provision? Psychooncology 2013; 22: 490-498.

19 

Gupta DMarkman MRodeghier Met al.. The relationship between patient satisfaction with service quality and survival in pancreatic cancer. Patient Prefer Adherence 2012; 6: 765-772.

20 

Gupta DLis CGRodeghier M. Can patient experience with service quality predict survival in colorectal cancer? J Health Qual 2013; 35: 37-43.

21 

Gupta DRodeghier MLis CG. Patient satisfaction with service quality in an oncology setting: implications for prognosis innon-small cell lung cancer. Int J Qual Health Care 2013; 25: 696-703.

22 

Gupta DRodeghier MLis CG. Patient satisfaction with service quality as a predictor of survival outcomes in breast cancer. Support Care Cancer 2014; 22: 129-134.

23 

Norton TRManne, SLRubin Set al.. Prevalence and predictors of psychological distress among women with ovarian cancer. J Clin Oncol 2004; 22: 919-926.

24 

Roland KBRodriguez JLPatterson JRet al.. A literature review of the social and psychological needs of ovarian cancer survivors. Psychooncology 2013; 22: 2408-2418.

25 

Costanzo ESLutgendorf SKRothrock NEet al.. Coping and quality of life among women extensively treated for gynecologic cancer. Psychooncology 2006; 15: 132-142.

26 

Tabano MCondosta DCoons M. Symptoms affecting quality of life in women with gynecologic cancer. Semin Oncol Nurs 2002; 18: 223-230.

27 

Stewart DEWong FCheung AMet al.. Information needs and decisional preferences among women with ovarian cancer. Gynecol Oncol 2000; 77: 357-361.

28 

Hack TFDegner LFParker Pet al.. The communication goals and needs of cancer patients: A review. Psychooncology 2005; 14: 831-845.

29 

Jefford MTattersall MH. Informing and involving cancer patients in their own care. Lancet Oncol 2002; 3: 629-637.

30 

Lantz PMJanz NKFagerlin Aet al.. Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer. Health Serv Res 2005; 40: 745-767.

31 

Catt SJenkins VMonson Ket al.. UK women with advanced ovarian cancer need more support. Psychooncology 2013; 22: 31.

32 

Miller BEPittman BStrong C. Gynecologic cancer patients’ psychosocial needs and their views on the physician’s role in meeting those needs. Int J Gynecol Cancer 2003; 13: 111-119.

33 

Browall MCarlsson MHorvath G. Information needs of women with recently diagnosed ovarian cancer—a longitudinal study. Eur J Oncol Nurs 2004; 8: 200-207.

34 

Ekwall ETernestedt BMSorbe Bet al.. Patients’ perceptions of communication with the health care team during chemotherapy for the first recurrence of ovarian cancer. Eur J Oncol Nurs 2011; 15: 53-58.

35 

Tagliaferri LManfrida SBarbaro Bet al.. MITHRA–multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: a feasibility study. J Contemp Brachytherapy 2015; 7: 336-345.

36 

Tagliaferri LBussu FRigante Met al.. Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences. Brachytherapy 2015; 14: 419-425.

37 

Tagliaferri LPagliara MMBoldrini Let al.. INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures. J Contemp Brachytherapy 2017; 9: 287-295.

38 

Kagawa-Singer M. A strategy to reduce cross-cultural miscommunication and increase the likelihood of improving health outcomes. Acad Med 2003; 78: 577-587.

39 

Betancourt JR. Cross-cultural medical education: conceptual approaches and frameworks for evaluation. Acad Med 2003; 78: 560-569.

40 

Surbone A. Cultural competence: why? Ann Oncol 2004; 15: 697-699.

41 

Seibert PSStridh-Igo PZimmmermann CG. A checklist to facilitate cultural awareness and sensitivity. J Med Ethics 2002; 28: 143-146.

42 

Jepson RGHewison JThompson Aet al.. Patient perspectives on information and choice in cancer screening: a qualitative study in the UK. Soc Sci Med 2007; 65: 890-899.

43 

Hack TFPickles TRuetheret al.. Predictors of distress and quality of life in patients undergoing cancer therapy: Impact of treatment type and decisional role. Psychooncology 2010; 19: 606-616.

44 

Step MMSiminoff LARosa JH. Differences in oncologist communication across age groups and contributions to adjuvant decision outcomes. J Am Geriatr Soc 2009; 57: S279-S282.

45 

Repetto LPiselli PRaffaele Met al.. Communicating cancer diagnosis and prognosis: when the target is the elderly patient-a GIOGer study. Eur J Cancer 2009; 45: 374-383.

46 

Temel JSGreer JAAdmane Set al.. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol 2011; 29: 2319-2326.

47 

Weeks JCCatalano PJCronin Aet al.. Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 2012; 367: 1616-1625.

48 

Lutgendorf SKAnderson BUllrich Pet al.. Quality of life and mood in women with gynecologic. A one year prospective study. Cancer 2002; 94: 131-140.

49 

Pinquart MDuberstein PR. Information needs and decision-making processes in older cancer patients. Crit Rev Oncol Hematol 2004; 51: 69-80.

50 

Lancellotta VKovács GTagliaferri Let al.. Age is not a limiting factor in interventional radiotherapy (brachytherapy) for patients with localized cancer. Biomed Res Int 2018; 2018: 2178469.

51 

Ferrandina GLucidi APaglia Aet al.. Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complications. Eur J Surg Oncol 2012; 38: 238-244.

52 

Montgomery GHBovbjerg DHSchnur JBet al.. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst 2007; 99: 1304-1312.

53 

Saadat HDrummond-Lewis JMaranets Iet al.. Hypnosis reduces preoperative anxiety in adult patients. Anesth Analg 2006; 102: 1394-1396.

54 

Wang SMPeloquin CKain ZN. The use of auricular acupuncture to reduce preoperative anxiety. Anesth Analg 2001; 93: 1178-1180.

55 

Autorino RTagliaferri LCampitelli Met al.. EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis. J Contemp Brachytherapy 2018; 10: 315-320.

56 

Bussu FTagliaferri LMattiucci Get al.. Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas. Laryngoscope 2016; 126: 367-371.

57 

Enck PBingel U,Schedlowski Met al.. OPINION the placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov 2013; 12: 191-204.

58 

Finniss DGKaptchuk TJMiller Fet al.. Clinical, and ethical advances of placebo effects. Lancet 2010; 375: 686-695.

59 

Schedlowski MEnck PRief Wet al.. Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice. Pharmacol Rev 2015; 67: 697-730.

60 

Colloca LKlinger RFlor Het al.. Placebo analgesia: psychological and neurobiological mechanisms. Pain 2013; 154: 511-514.

61 

Klinger RColloca LBingel Uet al.. Placebo analgesia: clinical applications. Pain 2014; 155: 1055-1058.

62 

Wager TDAtlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci 2015; 16: 403-418.

63 

Brody HMiller FG. Lessons from recent research about the placebo effect–from art to science. JAMA 2011; 306: 2612-2613.

64 

Peerdeman KJvan Laarhoven AIKeij SMet al.. Relieving patients’ pain with expectation interventions: a meta-analysis. Pain 2016; 157: 1179-1191.

65 

Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol Rev 2013; 93: 1207-1246.

66 

Kaptchuk TJKelley JMConboy LAet al.. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003.

67 

Moore S. Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 2007; 30: 112-122.

Copyright: © 2019 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe